1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
44.47 -1.11 (-2.44%)
100.32% Gain from 52W Low
661.3K
XNAS Volume

XNAS 15 Jul, 2025 1:12 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Mid Valuation
43.3 / 100
Momentum Score
Technically Bullish
70.8 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
46
1Yr Price target upside is 3%
19 analysts

26

S

6

W

5

O

0

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..